Davood Khalili - Search Results

Year	Number of Results
2009	1
2010	3
2011	3
2012	7
2013	5
2014	7
2015	12
2016	15
2017	18
2018	15
2019	22
2020	22
2021	40
2022	24
2023	28
2024	13

1

Optimizing cardiovascular disease mortality prediction: a super learner approach in the tehran lipid and glucose study.

Darabi P, Gharibzadeh S, Khalili D, Bagherpour-Kalo M, Janani L. Darabi P, et al. Among authors: khalili d. BMC Med Inform Decis Mak. 2024 Apr 16;24(1):97. doi: 10.1186/s12911-024-02489-0. BMC Med Inform Decis Mak. 2024. PMID: 38627734 Free PMC article.

2

Impact of optimal cholesterol levels on subclinical atherosclerosis in the absence of risk factors in young adults.

Masrouri S, Tamehri Zadeh SS, Shapiro MD, Khalili D, Hadaegh F. Masrouri S, et al. Among authors: khalili d. Atherosclerosis. 2024 Mar 17:117520. doi: 10.1016/j.atherosclerosis.2024.117520. Online ahead of print. Atherosclerosis. 2024. PMID: 38616451

3

The synergistic effect of obesity and dyslipidemia on hypertension: results from the STEPS survey.

Mohseni P, Khalili D, Djalalinia S, Mohseni H, Farzadfar F, Shafiee A, Izadi N. Mohseni P, et al. Among authors: khalili d. Diabetol Metab Syndr. 2024 Apr 3;16(1):81. doi: 10.1186/s13098-024-01315-x. Diabetol Metab Syndr. 2024. PMID: 38566160 Free PMC article.

4

Higher ultra-processed food intake is associated with an increased incidence risk of cardiovascular disease: the Tehran lipid and glucose study.

Jalali M, Bahadoran Z, Mirmiran P, Khalili D, Symonds ME, Azizi F, Faghih S. Jalali M, et al. Among authors: khalili d. Nutr Metab (Lond). 2024 Mar 19;21(1):14. doi: 10.1186/s12986-024-00788-x. Nutr Metab (Lond). 2024. PMID: 38504359 Free PMC article.

5

Establishing research impact assessment in Iran: The first report from a non-high-income country.

Yazdizadeh B, Ahmadi A, Najafi F, Mohammad K, Fariden M, Khalili D, Mahdavi M, Rahimpour E, Jouyban A, Kelishadi R, Monazzam MR, Eftekhari MB, Falahat K, Nikooee S, Majdzadeh R. Yazdizadeh B, et al. Among authors: khalili d. J Glob Health. 2024 Mar 15;14:04050. doi: 10.7189/jogh.14.04050. J Glob Health. 2024. PMID: 38483444 Free PMC article.

6

Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults.

NCD Risk Factor Collaboration (NCD-RisC). NCD Risk Factor Collaboration (NCD-RisC). Lancet. 2024 Mar 16;403(10431):1027-1050. doi: 10.1016/S0140-6736(23)02750-2. Epub 2024 Feb 29. Lancet. 2024. PMID: 38432237 Free PMC article.

7

The Tehran longitudinal family-based cardiometabolic cohort study sheds new light on dyslipidemia transmission patterns.

Akbarzadeh M, Riahi P, Saeidian AH, Zarkesh M, Masjoudi S, Asgarian S, Guity K, Moheimani H, Masoudi H, Roudbar MA, Khalili D, Hosseinpanah F, Barzin M, Hogan CT, Hakonarson H, Hedayati M, Daneshpour MS, Azizi F. Akbarzadeh M, et al. Among authors: khalili d. Sci Rep. 2024 Feb 27;14(1):4739. doi: 10.1038/s41598-024-53504-3. Sci Rep. 2024. PMID: 38413617 Free PMC article.

8

The difference between 2-hour post-challenge and fasting plasma glucose associates with the risk of cardiovascular disease in a normoglycemic population: the Tehran lipid and glucose study.

Abdi A, Kohansal K, Khalili D, Azizi F, Hadaegh F. Abdi A, et al. Among authors: khalili d. Nutr Metab (Lond). 2024 Feb 22;21(1):10. doi: 10.1186/s12986-024-00782-3. Nutr Metab (Lond). 2024. PMID: 38389086 Free PMC article.

9

Impact of coronary artery calcium on mortality and cardiovascular events in metabolic syndrome and diabetes among younger adults.

Masrouri S, Shapiro MD, Khalili D, Hadaegh F. Masrouri S, et al. Among authors: khalili d. Eur J Prev Cardiol. 2024 Apr 18;31(6):744-753. doi: 10.1093/eurjpc/zwae039. Eur J Prev Cardiol. 2024. PMID: 38323650

10

Alterations in CD4+ T Cell Cytokines Profile in Female Patients with Hashimoto's Thyroiditis Following Vitamin D Supplementation: A Double-blind, Randomized Clinical Trial.

Chahardoli R, Robat-Jazi B, Azizi F, Amouzegar A, Khalili D, Zadeh-Vakili A, Mansouri F, Saboor-Yaraghi AA. Chahardoli R, et al. Among authors: khalili d. Endocr Metab Immune Disord Drug Targets. 2024 Jan 25. doi: 10.2174/0118715303273297231226153751. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38284726

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

217 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Results by year